Skip to main content

Advertisement

SpringerLink
Log in

Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment

  • Original Paper
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

The purpose of the study was to evaluate the effect of reduced-fluence photodynamic therapy (RFPDT) for chronic central serous chorioretinopathy (CSC) associated with serous retinal detachment (SRD) and fovea-involving pigment epithelial detachment (PED). Ten eyes of ten patients with chronic CSC associated with combined SRD and PED involving the fovea were included. RFPDT was applied to the hyperfluorescent area identified at the mid-to-late phase of indocyanine green angiography, which indicated the area of leakage. We evaluated the changes in best-corrected visual acuity (BCVA) and optical coherence tomography at month 1 and final follow-up visit. The mean age of the participants was 47.4 ± 7 years. The mean follow-up duration was 6.3 ± 4 months. At month 3, the SRD had resolved completely in all ten eyes (100 %), and PED had resolved in seven eyes (70 %). The initial mean BCVA improved from 20/50 at baseline to 20/32 at the last visit (P > 0.05). The mean central retinal thickness was reduced from 534 ± 279 µm at baseline to 194 ± 46 µm at the last examination (P < 0.001). The mean subfoveal choroidal thickness decreased from 461 ± 57 at baseline to 369 ± 75 at the final visit (P < 0.001). Reduced-fluence PDT appears as an effective treatment for chronic CSC cases associated with SRD and fovea-involving PED.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Piccolino FC, Borgia L, Zinicola E, Zingirian M (1995) Indocyanine green angiographic findings in central serous chorioretinopathy. Eye (Lond) 9:324–332

    Article  Google Scholar 

  2. Nicholson B, Noble J, Forooghian F, Meyerle C (2013) Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol 58:103–126. doi:10.1016/j.survophthal.2012.07.004

    Article  PubMed  PubMed Central  Google Scholar 

  3. Levine R, Brucker AJ, Robinson F (1989) Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography. Ophthalmol 96:854–859

    Article  CAS  Google Scholar 

  4. Loo RH, Scott IU, Flynn HW Jr et al (2002) Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy. Retina 22:19–24

    Article  PubMed  Google Scholar 

  5. Yannuzzi LA, Slakter JS, Gross NE et al (2003) Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina 23:288–298

    Article  PubMed  Google Scholar 

  6. Chan WM, Lam DS, Lai TY et al (2003) Choroidal vascular remodeling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol 87:1453–1458

    Article  PubMed  PubMed Central  Google Scholar 

  7. Taban M, Boyer DS, Thomas EL, Taban M (2004) Chronic central serous chorioretinopathy: photodynamic therapy. Am J Ophthalmol 137:1073–1080

    Article  PubMed  Google Scholar 

  8. Erikitola OC, Crosby-Nwaobi R, Lotery AJ, Sivaprasad S (2014) Photodynamic therapy for central serous chorioretinopathy. Eye (Lond) 28:944–957. doi:10.1038/eye.2014.134

    Article  CAS  Google Scholar 

  9. Chan WM, Lai TY, Lai RY, Liu DT, Lam DS (2008) Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial. Ophthalmology 115:1756–1765

    Article  PubMed  Google Scholar 

  10. Lai TY, Chan WM, Li H, Lai RY, Liu DT, Lam DS (2006) Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study. Br J Ophthalmol 90:869–874

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Shin JY, Woo SJ, Yu HG, Park KH (2011) Comparison of efficacy and safety between half-fluence and full-fluence photodynamic therapy for chronic central serous chorioretinopathy. Retina 31:119–126. doi:10.1097/IAE.0b013e3181e378f2

    Article  CAS  PubMed  Google Scholar 

  12. Senturk F, Karacorlu M, Ozdemir H, Karacorlu SA, Uysal O (2011) Microperimetric changes after photodynamic therapy for central serous chorioretinopathy. Am J Ophthalmol 151:303–309. doi:10.1016/j.ajo.2010.08.019

    Article  PubMed  Google Scholar 

  13. Chan WM, Lai TY, Lai RY, Tang EW, Liu DT, Lam DS (2008) Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study. Retina 28:85–93. doi:10.1097/IAE.0b013e318156777f

    Article  PubMed  Google Scholar 

  14. Baran NV, Gurlu VP, Esgin H (2005) Long-term macular function in eyes with central serous chorioretinopathy. Clin Exp Ophthalmol 33:369–372

    Article  PubMed  Google Scholar 

  15. Mudvari SS, Goff MJ, Fu AD (2007) The natural history of pigment epithelial detachment associated with central serous chorioretinopathy. Retina 27:1168–1173

    Article  PubMed  Google Scholar 

  16. Lim JI, Glassman AR, Aiello LP et al (2014) Collaborative retrospective macula society study of photodynamic therapy for chronic central serous chorioretinopathy. Ophthalmology 121:1073–1078. doi:10.1016/j.ophtha.2013.11.040

    Article  PubMed  Google Scholar 

  17. Axer-Siegel R, Ehrlich R, Rosenblatt I et al (2004) Photodynamic therapy for occult choroidal neovascularization with pigment epithelial detachment in age-related macular degeneration. Arch Ophthalmol 122:453–459

    Article  PubMed  Google Scholar 

  18. Ruiz-Moreno JM, Lugo FL, Armadá F et al (2010) Photodynamic therapy for chronic central serous chorioretinopathy. Acta Ophthalmol 88:371–376. doi:10.1111/j.1755-3768.2008.01408

    Article  PubMed  Google Scholar 

  19. Goto S, Gomi F, Ueno C, Nishida K (2012) Reduced-fluence photodynamic therapy for subfoveal serous pigment epithelial detachment with choroidal vascular hyperpermeability. Am J Ophthalmol 154:865–871. doi:10.1016/j.ajo.2012.05.001

    Article  PubMed  Google Scholar 

  20. Shinojima A, Kawamura A, Mori R, Fujita K, Yuzawa M (2011) Detection of morphologic alterations by spectral-domain optical coherence tomography before and after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy. Retina 31:1912–1920. doi:10.1097/IAE.0b013e3182252aa8

    Article  CAS  PubMed  Google Scholar 

  21. Moon JW, Yu HG, Kim TW, Kim HC, Chung H (2009) Prognostic factors related to photodynamic therapy for central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 247:1315–1323. doi:10.1007/s00417-009-1104-8

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

We thank O. Uysal for assistance with statistical analysis.

Funding/support

This research received no specific Grant from any funding agency in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

  1. Istanbul RETINA Institute, Hakkı Yeten Cad. Unimed Center No: 19/7 Fulya Şişli, Istanbul, 34349, Turkey

    Serra Arf, Mumin Hocaoglu, Isil Sayman Muslubas & Murat Karacorlu

Authors
  1. Serra Arf
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mumin Hocaoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Isil Sayman Muslubas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Murat Karacorlu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Murat Karacorlu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Arf, S., Hocaoglu, M., Sayman Muslubas, I. et al. Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment. Int Ophthalmol 37, 483–489 (2017). https://doi.org/10.1007/s10792-016-0286-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-016-0286-4

Keywords

Search

Navigation